Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
Clinical outcomes following ibrutinib and idelalisib-based therapy in CLL: A retrospective analysis
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.